- Fourth quarter 2024 net loss of $40.7
million, or basic loss per common share of $0.47 per share
- Fourth quarter 2024 Adjusted EBITDA of $56.6 million
- Announces sale of Royal Purple® industrial business for
$110 million
- Montana Renewables received initial funds from U.S. Department
of Energy ("DOE") loan in February
2025
- Specialties business posts record sales volume and cost
improvement in 2024
INDIANAPOLIS, Feb. 28,
2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT)
today reported results of Calumet, Inc. (the "Company," "Calumet,"
"we," "our" or "us") for the fourth quarter ended December 31, 2024, as follows:
|
|
Three Months Ended
December 31,
|
|
Year Ended
December 31,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
(Dollars in millions, except per share/unit data)
|
Net income
(loss)
|
|
$
|
(40.7)
|
|
$
|
(48.0)
|
|
$
|
(222.0)
|
|
$
|
48.1
|
Basic earnings (loss)
per common share/unit
|
|
$
|
(0.47)
|
|
$
|
(0.59)
|
|
$
|
(2.67)
|
|
$
|
0.59
|
Adjusted
EBITDA
|
|
$
|
56.6
|
|
$
|
39.7
|
|
$
|
194.8
|
|
$
|
260.5
|
|
|
Specialty Products and Solutions
|
|
Performance Brands
|
|
Montana/Renewables
|
|
|
Three Months Ended
December 31,
|
|
Three Months Ended
December 31,
|
|
Three Months Ended
December 31,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
(Dollars in millions, except per barrel data)
|
Gross profit
(loss)
|
|
$
|
62.3
|
|
$
|
88.1
|
|
$
|
25.2
|
|
$
|
16.1
|
|
$
|
(3.9)
|
|
$
|
(82.1)
|
Adjusted gross profit
(loss)
|
|
$
|
50.6
|
|
$
|
69.6
|
|
$
|
25.7
|
|
$
|
16.5
|
|
$
|
19.1
|
|
$
|
(19.3)
|
Adjusted
EBITDA
|
|
$
|
43.4
|
|
$
|
75.6
|
|
$
|
16.3
|
|
$
|
6.1
|
|
$
|
10.9
|
|
$
|
(25.8)
|
Gross profit (loss) per
barrel
|
|
$
|
11.00
|
|
$
|
16.11
|
|
$
|
170.27
|
|
$
|
135.29
|
|
$
|
(1.87)
|
|
$
|
(45.76)
|
Adjusted gross profit
(loss) per barrel
|
|
$
|
8.93
|
|
$
|
12.73
|
|
$
|
173.65
|
|
$
|
138.66
|
|
$
|
9.15
|
|
$
|
(10.76)
|
|
|
Specialty Products and Solutions
|
|
Performance Brands
|
|
Montana/Renewables
|
|
|
Year Ended
December 31,
|
|
Year Ended
December 31,
|
|
Year Ended
December 31,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
(Dollars in millions, except per barrel data)
|
Gross profit
(loss)
|
|
$
|
189.0
|
|
$
|
402.2
|
|
$
|
95.3
|
|
$
|
82.1
|
|
$
|
(53.5)
|
|
$
|
(32.6)
|
Adjusted gross
profit
|
|
$
|
214.5
|
|
$
|
291.0
|
|
$
|
98.6
|
|
$
|
78.5
|
|
$
|
51.9
|
|
$
|
59.8
|
Adjusted
EBITDA
|
|
$
|
193.6
|
|
$
|
251.2
|
|
$
|
57.4
|
|
$
|
47.9
|
|
$
|
16.7
|
|
$
|
30.2
|
Gross profit (loss) per
barrel
|
|
$
|
8.26
|
|
$
|
18.73
|
|
$
|
152.24
|
|
$
|
160.35
|
|
$
|
(6.14)
|
|
$
|
(4.56)
|
Adjusted gross profit
per barrel
|
|
$
|
9.38
|
|
$
|
13.56
|
|
$
|
157.51
|
|
$
|
153.32
|
|
$
|
5.95
|
|
$
|
8.36
|
"The past twelve months of strategic activity at Calumet has
fundamentally reset the company's foundation," said Todd Borgmann, CEO. "Successfully completing the
conversion to a C-Corporation, receiving the first DOE funding
under the new administration, derisking Montana Renewables
operations, and continuing to widen the competitive moat around our
Specialties business positions the company to succeed against our
top priority of deleveraging the balance sheet and growing cash
flows."
"With receipt of funding from the DOE in February 2025, we have completely recapitalized
Montana Renewables, which eliminates approximately $80 million annually during the construction
period that was previously used for third-party debt service and
sets the stage for growth through our MaxSAF™ expansion. In
addition to the large cash flow unlocked through this loan, today's
announced sale of the Royal Purple® industrial business
demonstrates the next step in our commitment to accelerate the
deleveraging of our company."
Specialty Products and Solutions (SPS): The SPS segment
reported Adjusted EBITDA of $43.4
million during the fourth quarter of 2024 compared to
Adjusted EBITDA of $75.6 million for
the same quarter a year ago. Segment results reflected strong
production levels partially offsetting headwinds in fuels
reflecting negative crack spreads.
Performance Brands (PB): The PB segment reported
Adjusted EBITDA of $16.3 million
during the fourth quarter of 2024 versus Adjusted EBITDA of
$6.1 million in the fourth quarter of
2023, benefitting from 15 percent growth in year-over-year
volumes.
Montana/Renewables (MR):
The MR segment reported $10.9 million
of Adjusted EBITDA during the fourth quarter of 2024 compared to
Adjusted EBITDA of $(25.8) million in
the prior year period. Fourth quarter results reflect
continued operating momentum in our renewables business and the
receipt of an insurance claim, partially offset by the impact of a
planned turnaround in the fourth quarter of 2024. The
turnaround was successfully completed during the quarter and the
site resumed normal operations in December 2024.
Corporate: Total corporate costs represent $(14.0) million of Adjusted EBITDA for the fourth
quarter 2024. This compares to $(16.2)
million of Adjusted EBITDA in the fourth quarter 2023.
Calumet Announces Sale of Assets Related to Industrial
Portion of its Royal Purple® Business
Calumet announced it has entered into a definitive agreement
with a wholly owned subsidiary of Lubrication Engineers, Inc., a
portfolio company of Aurora Capital Partners, to sell assets
related to the industrial portion of its Royal Purple® business,
for $110 million. Calumet will
retain and continue to grow the consumer portion of the Royal
Purple business and the Royal Purple production facility in
Porter, TX.
The transaction of Royal Purple's high performance synthetic
industrial product line include industrial gear lubricants,
bio-environmental lubricants, stationary natural gas engine oils,
hydraulic lubricants, and compressor oils, along with an exclusive
license of the brand for industrial applications. During the
year ended December 31, 2024, Royal
Purple's industrial business generated approximately $29 million of total sales.
Calumet will retain ownership of the Porter, Texas, manufacturing site and the
consumer portion of the Royal Purple business, which caters to a
diverse array of automotive product applications through a
multi-channel strategy of leading national retail outlets and
specialty auto parts stores. Key brands within the consumer
portion of Royal Purple include: High Performance Motor Oil, HPS®,
HMX®, Max EZ®, Max Gear®, Max-Clean®, XPR®, and Duralec
Super™.
The Company expects to use the sale proceeds to primarily pay
down debt. The transaction is expected to close in the first half
of 2025, subject to customary closing conditions.
Calumet Specialty Products Partners, L.P. Completes
Conversion to C-Corporation
As previously announced in July 2024, Calumet Specialty
Products Partners, L.P. completed the previously announced
conversion (the "Conversion") of its structure from an MLP to a
C-Corporation, pursuant to which the unitholders of Calumet
Specialty Products Partners, L.P. (the "Partnership") became
shareholders of Calumet, Inc. As previously announced, at the
Partnership's special meeting of unitholders held on July 9, 2024, over 99% of the votes cast on the
Conversion proposal were cast in favor of the approval of the
Conversion. The Partnership's unitholders also voted to approve all
other proposals presented at the special meeting.
Montana Renewables Receives First Drawdown from $1.44 Billion DOE Loan Facility
Calumet announced on February 18,
2025, that Montana Renewables, LLC, an unrestricted
subsidiary of Calumet received its first drawdown of approximately
$782 million from its $1.44 billion guaranteed loan facility with the
DOE Loan Programs Office ("LPO"). The loan funds the construction
and expansion of the renewable fuels facility owned by Montana
Renewables.
The expansion positions Montana Renewables as one of the largest
Sustainable Aviation Fuel ("SAF") producers globally, enabling an
increase in annual production capacity to approximately 300 million
gallons of SAF and 330 million gallons of combined SAF and
renewable diesel. The planned expansion includes several key
modular components, which will provide the ability to increase
capacity and reduce costs. The most important component is a second
renewable fuels reactor, which will allow approximately half of the
300-million-gallon SAF capability to be online by 2026.
The loan guarantee is structured in two tranches, with the first
tranche of approximately $782 million
released to fund eligible expenses previously incurred by MRL.
Simultaneous with the first tranche funding, Calumet made an
additional $150 million equity
investment in Montana Renewables Holdings LLC, the parent company
of MRL, with cash on hand. The balance of the guaranteed loan
proceeds of up to approximately $658
million is expected to be disbursed through a delayed draw
construction facility, and MRL expects this second tranche to be
disbursed during construction beginning in 2025 through the
anticipated completion of the MaxSAF™ project in
2028. Disbursements under the guaranteed loan facility are
subject to the satisfaction of certain commercial, technical, and
legal conditions precedent. During construction, retained earnings
from MRL are expected to supplement DOE funds to maintain debt at
55% of capitalization during the MaxSAF™ construction sequence. The
loan has a 15-year tenor and an annual interest rate at the U.S.
Treasury rate plus 3/8%. Servicing of principal and interest will
be deferred until MaxSAF™ is commissioned.
Operations Summary
The following table sets forth information about the Company's
continuing operations after giving effect to the elimination of all
intercompany activity. Facility production volume differs from
sales volume due to changes in inventories and the sale of
purchased blendstocks such as ethanol and specialty blendstocks, as
well as the resale of crude oil.
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
December 31,
|
|
Year Ended
December 31,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
(In bpd)
|
|
(In bpd)
|
Total sales volume
(1)
|
|
85,882
|
|
80,234
|
|
88,007
|
|
79,805
|
Facility
production:
|
|
|
|
|
|
|
|
|
Specialty Products and
Solutions:
|
|
|
|
|
|
|
|
|
Lubricating
oils
|
|
12,804
|
|
11,381
|
|
12,174
|
|
10,358
|
Solvents
|
|
7,493
|
|
7,303
|
|
7,570
|
|
7,208
|
Waxes
|
|
1,613
|
|
1,200
|
|
1,540
|
|
1,326
|
Fuels, asphalt and
other by-products
|
|
39,801
|
|
40,141
|
|
36,396
|
|
37,353
|
Total Specialty
Products and Solutions
|
|
61,711
|
|
60,025
|
|
57,680
|
|
56,245
|
Montana/Renewables:
|
|
|
|
|
|
|
|
|
Gasoline
|
|
3,660
|
|
3,919
|
|
3,556
|
|
3,898
|
Diesel
|
|
2,903
|
|
2,862
|
|
2,830
|
|
2,941
|
Jet fuel
|
|
338
|
|
370
|
|
472
|
|
449
|
Asphalt, heavy fuel
oils and other
|
|
3,667
|
|
4,512
|
|
3,983
|
|
4,483
|
Renewable
fuels
|
|
7,865
|
|
5,442
|
|
9,848
|
|
6,314
|
Total
Montana/Renewables
|
|
18,433
|
|
17,105
|
|
20,689
|
|
18,085
|
|
|
|
|
|
|
|
|
|
Performance
Brands
|
|
1,692
|
|
1,347
|
|
1,739
|
|
1,474
|
|
|
|
|
|
|
|
|
|
Total facility
production
|
|
81,836
|
|
78,477
|
|
80,108
|
|
75,804
|
|
|
|
|
|
|
|
|
|
(1)
|
Total sales volume
includes sales from the production at our facilities and certain
third-party facilities pursuant to supply and/or processing
agreements, sales of inventories and the resale of crude oil to
third-party customers. Total sales volume includes the sale of
purchased blendstocks.
|
Webcast Information
A conference call is scheduled for 9:00
a.m. ET on February 28, 2025,
to discuss the financial and operational results for the fourth
quarter of 2024. Investors, analysts and members of the media
interested in listening to the live presentation are encouraged to
join a webcast of the call with accompanying presentation slides,
available on Calumet's website at
www.calumet.investorroom.com/events. Interested parties may also
participate in the call by dialing (844) 695-5524. A replay of the
conference call will be available a few hours after the event on
the investor relations section of Calumet's website, under the
events and presentations section and will remain available for at
least 90 days.
About Calumet
Calumet, Inc. (NASDAQ: CLMT) manufactures, formulates, and
markets a diversified slate of specialty branded products and
renewable fuels to customers across a broad range of
consumer-facing and industrial markets. Calumet is headquartered in
Indianapolis, Indiana and operates
twelve facilities throughout North
America.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements and information in this press release may
constitute "forward-looking statements." The words "will," "may,"
"intend," "believe," "expect," "outlook," "forecast," "anticipate,"
"estimate," "continue," "plan," "should," "could," "would," or
other similar expressions are intended to identify forward-looking
statements, which are generally not historical in nature. The
statements discussed in this press release that are not purely
historical data are forward-looking statements, including, but not
limited to, the statements regarding (i) demand for finished
products in markets we serve, (ii) our expectation regarding our
business outlook and cash flows, including with respect to the
Montana Renewables business and our plans to de-leverage our
balance sheet, (iii) our expectations regarding the DOE loan
facility (the "DOE Facility"), including the timing, size and
intended use of borrowings under such facility, (iv) our
expectation that the DOE Facility will enable MRL to complete the
MaxSAF™ construction and that such project will be completed on
time and on budget, (v) our expectation regarding the time required
to consummate the proposed sale of the Royal Purple® industrial
business (the "Proposed Transaction") and the satisfaction or
waiver of conditions in the agreement governing the Proposed
Transaction, (vi) our ability to obtain regulatory or other
third-party approvals and consents and otherwise consummate the
Proposed Transaction, (vii) our ability to achieve the strategic
and other objectives relating to the Proposed Transaction, (viii)
our expectation regarding anticipated capital expenditures and
strategic initiatives, and (vii) our ability to meet our financial
commitments, debt service obligations, debt instrument covenants,
contingencies and anticipated capital expenditures. These
forward-looking statements are based on our current expectations
and beliefs concerning future developments and their potential
effect on us. While management believes that these forward-looking
statements are reasonable as and when made, there can be no
assurance that future developments affecting us will be those that
we anticipate. All comments concerning our current expectations for
future sales and operating results are based on our forecasts for
our existing operations and do not include the potential impact of
any future acquisition or disposition transactions. Our
forward-looking statements involve significant risks and
uncertainties (some of which are beyond our control) and
assumptions that could cause our actual results to differ
materially from our historical experience and our present
expectations or projections. Known material factors that could
cause our actual results to differ materially from those in the
forward-looking statements include: the overall demand for
specialty products, fuels, renewable fuels and other refined
products; the level of foreign and domestic production of crude oil
and refined products; our ability to produce specialty products,
fuel products, and renewable fuel products that meet our customers'
unique and precise specifications; the marketing of alternative and
competing products; the impact of fluctuations and rapid increases
or decreases in crude oil and crack spread prices, including the
resulting impact on our liquidity; the results of our hedging and
other risk management activities; our ability to comply with
financial covenants contained in our debt instruments; the
availability of, and our ability to consummate, acquisition or
combination opportunities and the impact of any completed
acquisitions; labor relations; our access to capital to fund
expansions, acquisitions and our working capital needs and our
ability to obtain debt or equity financing on satisfactory terms;
successful integration and future performance of acquired assets,
businesses or third-party product supply and processing
relationships; our ability to timely and effectively integrate the
operations of acquired businesses or assets, particularly those in
new geographic areas or in new lines of business; environmental
liabilities or events that are not covered by an indemnity,
insurance or existing reserves; maintenance of our credit ratings
and ability to receive open credit lines from our suppliers; demand
for various grades of crude oil and resulting changes in pricing
conditions; fluctuations in refinery capacity; our ability to
access sufficient crude oil supply through long-term or
month-to-month evergreen contracts and on the spot market; the
effects of competition; continued creditworthiness of, and
performance by, counterparties; the impact of current and future
laws, rulings and governmental regulations, including guidance
related to the Dodd-Frank Wall Street Reform and Consumer
Protection Act; the costs of complying with the Renewable Fuel
Standard, including the prices paid for renewable identification
numbers ("RINs"); shortages or cost increases of power supplies,
natural gas, materials or labor; hurricane or other weather
interference with business operations; our ability to access the
debt and equity markets; accidents or other unscheduled shutdowns;
and general economic, market, business or political conditions,
including inflationary pressures, instability in financial
institutions, general economic slowdown or a recession, political
tensions, conflicts and war (such as the ongoing conflicts in
Ukraine and the Middle East and their regional and global
ramifications).
For additional information regarding factors that could cause
our actual results to differ from our projected results, please see
our filings with the SEC, including the risk factors and other
cautionary statements in the Partnership's latest Annual Report on
Form 10-K and other filings with the SEC by Calumet and the
Partnership.
We caution that these statements are not guarantees of future
performance and you should not rely unduly on them, as they involve
risks, uncertainties, and assumptions that we cannot predict. In
addition, we have based many of these forward-looking statements on
assumptions about future events that may prove to be inaccurate.
While our management considers these assumptions to be reasonable,
they are inherently subject to significant business, economic,
competitive, regulatory and other risks, contingencies and
uncertainties, most of which are difficult to predict and many of
which are beyond our control. Accordingly, our actual results may
differ materially from the future performance that we have
expressed or forecast in our forward-looking statements. Readers
are cautioned not to place undue reliance on forward-looking
statements, which speak only as of the date they are made. We
undertake no obligation to publicly update or revise any
forward-looking statements after the date they are made, whether as
a result of new information, future events or otherwise, except to
the extent required by applicable law. Certain public statements
made by us and our representatives on the date hereof may also
contain forward-looking statements, which are qualified in their
entirety by the cautionary statements contained above.
Non-GAAP Financial Measures
Our management uses certain non-GAAP performance measures to
analyze operating segment performance and non-GAAP financial
measures to evaluate past performance and prospects for the future
to supplement our financial information presented in accordance
with generally accepted accounting principles ("GAAP"). These
financial and operational non-GAAP measures are important factors
in assessing our operating results and profitability and include
performance measures along with certain key operating metrics.
We use the following financial performance measures:
EBITDA: We define EBITDA for any period as net income (loss)
plus interest expense (including amortization of debt issuance
costs), income taxes and depreciation and amortization.
Historically, we considered net income (loss) to be the most
directly comparable GAAP measure to EBITDA. We believe net income
(loss) is the most directly comparable GAAP measure to EBITDA.
Adjusted EBITDA: We define Adjusted EBITDA for any period as:
EBITDA adjusted for (a) impairment; (b) unrealized gains and
losses from mark to market accounting for hedging activities;
(c) realized gains and losses under derivative instruments
excluded from the determination of net income (loss);
(d) non-cash equity-based compensation expense and other
non-cash items (excluding items such as accruals of cash expenses
in a future period or amortization of a prepaid cash expense) that
were deducted in computing net income (loss); (e) debt
refinancing fees, extinguishment costs, premiums and penalties; (f)
any net gain or loss realized in connection with an asset sale that
was deducted in computing net income (loss); (g) amortization of
turnaround costs; (h) LCM inventory adjustments; (i) the impact of
liquidation of inventory layers calculated using the LIFO method;
(j) RINs mark-to-market adjustments; and (k) all
extraordinary, unusual or non-recurring items of gain or loss, or
revenue or expense.
Specialty Products and Solutions segment Adjusted EBITDA Margin:
We define Specialty Products and Solutions segment Adjusted EBITDA
Margin for any period as Specialty Products and Solutions segment
Adjusted EBITDA divided by Specialty Products and Solutions segment
sales.
Specialty Products and Solutions segment Adjusted gross profit
(loss): We define Specialty Products and Solutions segment Adjusted
gross profit (loss) for any period as Specialty Products and
Solutions segment gross profit (loss) excluding the impact of (a)
LCM inventory adjustments; (b) the impact of liquidation of
inventory layers calculated using the LIFO method; (c) RINs
mark-to-market adjustments; (d) depreciation and amortization; and
(e) all extraordinary, unusual or non-recurring items of revenue or
cost of sales.
Performance Brands segment Adjusted gross profit (loss): We
define Performance Brands segment Adjusted gross profit (loss) for
any period as Performance Brands segment gross profit (loss)
excluding the impact of (a) LCM inventory adjustments; (b) the
impact of liquidation of inventory layers calculated using the LIFO
method; (c) RINs mark-to-market adjustments; (d) depreciation and
amortization; and (e) all extraordinary, unusual or non-recurring
items of revenue or cost of sales.
Montana/Renewables segment
Adjusted gross profit (loss): We define Montana/Renewables segment Adjusted gross
profit (loss) for any period as Montana/Renewables segment gross profit (loss)
excluding the impact of (a) LCM inventory adjustments; (b) the
impact of liquidation of inventory layers calculated using the LIFO
method; (c) RINs mark-to-market adjustments; (d) depreciation and
amortization; and (e) all extraordinary, unusual or non-recurring
items of revenue or cost of sales.
The definition of Adjusted EBITDA that is presented in this
press release is similar to the calculation of (i) "Consolidated
Cash Flow" contained in the indentures governing our 11.00% Senior
Notes due 2025 (the "2025 Notes"), our 8.125% Senior Notes due 2027
(the "2027 Notes"), each series of our 9.75% Senior Notes due 2028
(the "2028 Notes"), and our 9.25% Senior Secured First Lien Notes
due 2029 (the "2029 Secured Notes") and (ii) "Consolidated EBITDA"
contained in the credit agreement governing our revolving credit
facility. We are required to report Consolidated Cash Flow to the
holders of our 2025 Notes, 2027 Notes, 2028 Notes, and 2029 Secured
Notes and Consolidated EBITDA to the lenders under our revolving
credit facility, and these measures are used by them to determine
our compliance with certain covenants governing those debt
instruments. Please see our filings with the SEC, including our
most recent Annual Report on Form 10-K and Current Reports on Form
8-K, for additional details regarding the covenants governing our
debt instruments.
These non-GAAP measures are used as supplemental financial
measures by our management and by external users of our financial
statements such as investors, commercial banks, research analysts
and others, to assess:
- the financial performance of our assets without regard to
financing methods, capital structure or historical cost basis;
- the ability of our assets to generate cash sufficient to pay
interest costs and support our indebtedness;
- our operating performance and return on capital as compared to
those of other companies in our industry, without regard to
financing or capital structure;
- the viability of acquisitions and capital expenditure projects
and the overall rates of return on alternative investment
opportunities; and
- our operating performance excluding the non-cash impact of LCM
and LIFO inventory adjustments, RINs mark-to-market adjustments,
and depreciation and amortization.
We believe that these non-GAAP measures are useful to analysts
and investors, as they exclude transactions not related to our core
cash operating activities and provide metrics to analyze our
ability to fund our capital requirements and to pay interest on our
debt obligations. We believe that excluding these transactions
allows investors to meaningfully analyze trends and performance of
our core cash operations.
EBITDA, Adjusted EBITDA, and segment Adjusted gross profit
(loss) should not be considered alternatives to Net income (loss),
Operating income (loss), Net cash provided by (used in) operating
activities, gross profit (loss) or any other measure of financial
performance presented in accordance with GAAP. In evaluating our
performance as measured by EBITDA, Adjusted EBITDA, and segment
Adjusted gross profit (loss) management recognizes and considers
the limitations of these measurements. EBITDA and Adjusted EBITDA
do not reflect our liabilities for the payment of income taxes,
interest expense or other obligations such as capital expenditures.
Accordingly, EBITDA, Adjusted EBITDA, and segment Adjusted gross
profit (loss) are only a few of several measurements that
management utilizes. Moreover, our EBITDA, Adjusted EBITDA, and
segment Adjusted gross profit (loss) may not be comparable to
similarly titled measures of another company because all companies
may not calculate EBITDA, Adjusted EBITDA, and segment Adjusted
gross profit (loss) in the same manner. Please see the section of
this release entitled "Non-GAAP Reconciliations" for tables that
present reconciliations of EBITDA and Adjusted EBITDA to Net income
(loss), our most directly comparable GAAP financial performance
measure; and segment Adjusted gross profit (loss) to segment gross
profit (loss), our most directly comparable GAAP financial
performance measure.
CALUMET,
INC. CONSOLIDATED STATEMENTS OF OPERATIONS (In
millions, except share/unit and per share/unit data)
|
|
|
|
Three Months Ended
December 31,
|
|
Year Ended
December 31,
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Sales
|
|
$
|
949.5
|
|
$
|
976.5
|
|
$
|
4,189.4
|
|
$
|
4,181.0
|
Cost of
sales
|
|
|
865.9
|
|
|
954.4
|
|
|
3,958.6
|
|
|
3,729.3
|
Gross profit
|
|
|
83.6
|
|
|
22.1
|
|
|
230.8
|
|
|
451.7
|
Operating costs and
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling
|
|
|
12.0
|
|
|
13.5
|
|
|
55.7
|
|
|
54.9
|
General and
administrative
|
|
|
44.5
|
|
|
30.0
|
|
|
145.5
|
|
|
133.0
|
Taxes other than income
taxes
|
|
|
2.8
|
|
|
5.9
|
|
|
20.7
|
|
|
21.5
|
Loss on impairment and
disposal of assets
|
|
|
2.0
|
|
|
3.5
|
|
|
2.0
|
|
|
3.5
|
Other operating
(income) expense
|
|
|
(0.4)
|
|
|
(16.9)
|
|
|
(1.2)
|
|
|
(28.4)
|
Operating income
(loss)
|
|
|
22.7
|
|
|
(13.9)
|
|
|
8.1
|
|
|
267.2
|
Other income
(expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
|
(61.4)
|
|
|
(58.0)
|
|
|
(236.7)
|
|
|
(221.7)
|
Debt extinguishment
costs
|
|
|
(0.1)
|
|
|
(0.4)
|
|
|
(0.4)
|
|
|
(5.9)
|
Gain (loss) on
derivative instruments
|
|
|
(0.3)
|
|
|
24.4
|
|
|
9.3
|
|
|
9.9
|
Other income
(expense)
|
|
|
(2.2)
|
|
|
0.1
|
|
|
(1.5)
|
|
|
0.2
|
Total other
expense
|
|
|
(64.0)
|
|
|
(33.9)
|
|
|
(229.3)
|
|
|
(217.5)
|
Net income (loss)
before income taxes
|
|
|
(41.3)
|
|
|
(47.8)
|
|
|
(221.2)
|
|
|
49.7
|
Income tax (benefit)
expense
|
|
|
(0.6)
|
|
|
0.2
|
|
|
0.8
|
|
|
1.6
|
Net income
(loss)
|
|
$
|
(40.7)
|
|
$
|
(48.0)
|
|
$
|
(222.0)
|
|
$
|
48.1
|
Allocation of net
income (loss) to partners:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
attributable to partners
|
|
|
|
|
$
|
(48.0)
|
|
|
|
|
$
|
48.1
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
General partners'
interest in net income (loss)
|
|
|
|
|
|
(1.0)
|
|
|
|
|
|
1.0
|
Net income (loss)
available to limited partners
|
|
|
|
|
$
|
(47.0)
|
|
|
|
|
$
|
47.1
|
Earnings per share /
Limited partners' interest net income (loss) per unit:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and
diluted
|
|
$
|
(0.47)
|
|
$
|
(0.59)
|
|
$
|
(2.67)
|
|
$
|
0.59
|
Weighted average number
of common shares / limited partner units outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and
diluted
|
|
|
86,089,979
|
|
|
80,174,931
|
|
|
83,146,680
|
|
|
80,075,530
|
CALUMET,
INC. CONSOLIDATED BALANCE SHEETS (In millions,
except share/unit data)
|
|
|
|
December 31, 2024
|
|
December 31, 2023
|
ASSETS
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
38.1
|
|
$
|
7.9
|
Accounts receivable,
net:
|
|
|
|
|
|
|
Trade, less allowance
for credit losses of $1.1 million and $1.2 million,
respectively
|
|
|
241.7
|
|
|
252.4
|
Other
|
|
|
36.4
|
|
|
33.8
|
|
|
|
278.1
|
|
|
286.2
|
Inventories
|
|
|
416.3
|
|
|
439.4
|
Derivative
assets
|
|
|
—
|
|
|
9.6
|
Prepaid expenses and
other current assets
|
|
|
33.5
|
|
|
51.6
|
Total current
assets
|
|
|
766.0
|
|
|
794.7
|
Property, plant and
equipment, net
|
|
|
1,438.8
|
|
|
1,506.3
|
Goodwill
|
|
|
173.0
|
|
|
173.0
|
Other intangible
assets, net
|
|
|
22.0
|
|
|
28.5
|
Operating lease
right-of-use assets
|
|
|
240.2
|
|
|
114.4
|
Other noncurrent
assets, net
|
|
|
118.2
|
|
|
134.4
|
Total assets
|
|
$
|
2,758.2
|
|
$
|
2,751.3
|
LIABILITIES AND
STOCKHOLDERS' EQUITY / PARTNERS' CAPITAL (DEFICIT)
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
320.8
|
|
$
|
322.0
|
Accrued interest
payable
|
|
|
45.4
|
|
|
48.7
|
Accrued salaries, wages
and benefits
|
|
|
94.7
|
|
|
87.1
|
Other taxes
payable
|
|
|
11.9
|
|
|
13.5
|
Obligations under
inventory financing agreements
|
|
|
32.0
|
|
|
190.4
|
Current portion of RINs
obligation
|
|
|
245.4
|
|
|
277.3
|
Current portion of
operating lease liabilities
|
|
|
58.8
|
|
|
75.6
|
Other current
liabilities
|
|
|
19.1
|
|
|
42.4
|
Current portion of
long-term debt
|
|
|
35.5
|
|
|
55.7
|
Total current
liabilities
|
|
|
863.6
|
|
|
1,112.7
|
Pension and
postretirement benefit obligations
|
|
|
4.0
|
|
|
4.2
|
Other long-term
liabilities
|
|
|
110.0
|
|
|
10.4
|
Long-term operating
lease liabilities
|
|
|
182.2
|
|
|
39.0
|
Long-term debt, less
current portion
|
|
|
2,064.7
|
|
|
1,829.7
|
Total
liabilities
|
|
$
|
3,224.5
|
|
$
|
2,996.0
|
Commitments and
contingencies
|
|
|
|
|
|
|
Redeemable
noncontrolling interest
|
|
$
|
245.6
|
|
$
|
245.6
|
Stockholders' equity /
partners' capital (deficit):
|
|
|
|
|
|
|
Common stock: par value
$0.01 per share, 700,000,000 shares authorized, and 85,950,493
shares issued and outstanding as of December 31, 2024.
|
|
$
|
0.9
|
|
$
|
—
|
Additional paid-in
capital
|
|
|
825.4
|
|
|
—
|
Warrants: 2,000,000
warrants issued and outstanding as of December 31, 2024.
|
|
|
7.8
|
|
|
—
|
Accumulated
deficit
|
|
|
(1,539.0)
|
|
|
—
|
Limited partners'
interest (79,967,363 units issued and outstanding at December 31,
2023.
|
|
|
—
|
|
|
(484.4)
|
General partners'
interest
|
|
|
—
|
|
|
1.3
|
Accumulated other
comprehensive loss
|
|
|
(7.0)
|
|
|
(7.2)
|
Total stockholders'
equity / partners' capital (deficit)
|
|
|
(711.9)
|
|
|
(490.3)
|
Total liabilities and
stockholders' equity / partners' capital (deficit)
|
|
$
|
2,758.2
|
|
$
|
2,751.3
|
CALUMET,
INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (In
millions)
|
|
|
|
Year Ended
December 31,
|
|
|
2024
|
|
2023
|
|
|
|
Operating
activities
|
|
|
|
|
|
|
Net income
(loss)
|
|
$
|
(222.0)
|
|
$
|
48.1
|
Adjustments to
reconcile net income (loss) to net cash used in operating
activities:
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
149.0
|
|
|
146.8
|
Amortization of
turnaround costs
|
|
|
38.0
|
|
|
36.1
|
Non-cash interest
expense
|
|
|
8.0
|
|
|
5.7
|
Debt extinguishment
costs
|
|
|
0.4
|
|
|
1.6
|
Non-cash RINs (gain)
expense
|
|
|
(31.9)
|
|
|
(199.1)
|
Unrealized (gain) loss
on derivative instruments
|
|
|
5.9
|
|
|
(33.0)
|
Loss on impairment and
disposal of assets
|
|
|
2.0
|
|
|
3.5
|
Equity based
compensation
|
|
|
14.6
|
|
|
14.7
|
Lower of cost or market
inventory adjustment
|
|
|
7.0
|
|
|
33.2
|
Other non-cash
activities
|
|
|
(7.0)
|
|
|
0.5
|
Changes in assets and
liabilities
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
8.0
|
|
|
(19.2)
|
Inventories
|
|
|
16.1
|
|
|
25.1
|
Prepaid expenses and
other current assets
|
|
|
17.9
|
|
|
(25.9)
|
Turnaround
costs
|
|
|
(20.6)
|
|
|
(47.9)
|
Other assets
|
|
|
(5.6)
|
|
|
(10.2)
|
Accounts
payable
|
|
|
1.7
|
|
|
(12.4)
|
Accrued interest
payable
|
|
|
(5.2)
|
|
|
15.3
|
Accrued salaries, wages
and benefits
|
|
|
4.0
|
|
|
(17.1)
|
Other taxes
payable
|
|
|
(1.6)
|
|
|
4.0
|
Other
liabilities
|
|
|
(25.1)
|
|
|
15.3
|
Net cash used in
operating activities
|
|
$
|
(46.4)
|
|
$
|
(14.9)
|
Investing
activities
|
|
|
|
|
|
|
Additions to property,
plant and equipment
|
|
|
(76.7)
|
|
|
(271.8)
|
Proceeds from sale of
property, plant and equipment
|
|
|
—
|
|
|
—
|
Net cash used in
investing activities
|
|
$
|
(76.7)
|
|
$
|
(271.8)
|
Financing
activities
|
|
|
|
|
|
|
Proceeds from
borrowings — revolving credit facility
|
|
|
2,129.2
|
|
|
2,185.0
|
Repayments of
borrowings — revolving credit facility
|
|
|
(1,979.3)
|
|
|
(2,152.3)
|
Proceeds from
borrowings — MRL revolving credit agreement
|
|
|
159.1
|
|
|
93.2
|
Repayments of
borrowings — MRL revolving credit agreement
|
|
|
(172.1)
|
|
|
(80.2)
|
Proceeds from
borrowings — senior notes
|
|
|
554.4
|
|
|
325.0
|
Repayments of
borrowings — senior notes
|
|
|
(592.5)
|
|
|
(121.0)
|
Payments on finance
lease obligations
|
|
|
(1.1)
|
|
|
(1.0)
|
Proceeds from inventory
financing
|
|
|
671.3
|
|
|
1,712.0
|
Payments on inventory
financing
|
|
|
(708.5)
|
|
|
(1,753.9)
|
Proceeds from other
financing obligations
|
|
|
144.7
|
|
|
102.0
|
Payments on other
financing obligations
|
|
|
(41.5)
|
|
|
(30.1)
|
Debt issuance
costs
|
|
|
(9.4)
|
|
|
(12.5)
|
Net cash provided by
financing activities
|
|
$
|
154.3
|
|
$
|
266.2
|
Net increase (decrease)
in cash, cash equivalents and restricted cash
|
|
$
|
31.2
|
|
$
|
(20.5)
|
Cash, cash equivalents
and restricted cash at beginning of period
|
|
$
|
14.7
|
|
$
|
35.2
|
Cash, cash equivalents
and restricted cash at end of period
|
|
$
|
45.9
|
|
$
|
14.7
|
Cash and cash
equivalents
|
|
$
|
38.1
|
|
$
|
7.9
|
Restricted
cash
|
|
$
|
7.8
|
|
$
|
6.8
|
Supplemental
disclosure of cash flow information
|
|
|
|
|
|
|
Interest paid, net of
capitalized interest
|
|
$
|
232.0
|
|
$
|
201.9
|
Supplemental
disclosure of non-cash investing activities
|
|
|
|
|
|
|
Non-cash property,
plant and equipment additions
|
|
$
|
30.7
|
|
$
|
31.3
|
CALUMET,
INC. NON-GAAP RECONCILIATIONS RECONCILIATION
OF NET INCOME (LOSS) TO EBITDA AND ADJUSTED
EBITDA (In millions)
|
|
|
|
Three Months Ended
December 31,
|
|
Year Ended
December 31,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of
Net income (loss) to EBITDA and Adjusted EBITDA:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
(loss)
|
|
$
|
(40.7)
|
|
$
|
(48.0)
|
|
$
|
(222.0)
|
|
$
|
48.1
|
Add:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
|
61.4
|
|
|
58.0
|
|
|
236.7
|
|
|
221.7
|
Depreciation and
amortization
|
|
|
40.9
|
|
|
50.2
|
|
|
149.0
|
|
|
146.9
|
Income tax
expense
|
|
|
(0.6)
|
|
|
0.2
|
|
|
0.8
|
|
|
1.6
|
EBITDA
|
|
$
|
61.0
|
|
$
|
60.4
|
|
$
|
164.5
|
|
$
|
418.3
|
Add:
|
|
|
|
|
|
|
|
|
|
|
|
|
LCM / LIFO
loss
|
|
$
|
3.4
|
|
$
|
26.2
|
|
$
|
12.3
|
|
$
|
35.6
|
Unrealized (gain) loss
on derivative instruments
|
|
|
5.2
|
|
|
(14.2)
|
|
|
(47.1)
|
|
|
(33.0)
|
Debt extinguishment
costs
|
|
|
0.1
|
|
|
0.4
|
|
|
0.4
|
|
|
5.9
|
Amortization of
turnaround costs
|
|
|
9.5
|
|
|
9.1
|
|
|
38.0
|
|
|
36.1
|
Loss on impairment and
disposal of assets
|
|
|
2.0
|
|
|
3.5
|
|
|
2.0
|
|
|
3.5
|
RINs mark-to-market
gain
|
|
|
(40.3)
|
|
|
(74.3)
|
|
|
(66.4)
|
|
|
(290.2)
|
Equity-based
compensation and other items
|
|
|
15.3
|
|
|
(0.8)
|
|
|
19.7
|
|
|
20.2
|
Other non-recurring
expenses (1)
|
|
|
3.4
|
|
|
25.4
|
|
|
75.5
|
|
|
60.9
|
Noncontrolling
interest adjustments
|
|
|
(3.0)
|
|
|
4.0
|
|
|
(4.1)
|
|
|
3.2
|
Adjusted
EBITDA
|
|
$
|
56.6
|
|
$
|
39.7
|
|
$
|
194.8
|
|
$
|
260.5
|
|
|
|
|
|
|
|
|
|
(1)
|
For the year ended
December 31, 2024, other non-recurring expenses included a $51.3
million realized loss on derivatives related to our inventory
financing arrangements. For the year ended December 31, 2023, other
non-recurring expenses included a $50.6 million charge to cost of
sales for losses under firm purchase commitments.
|
CALUMET,
INC. RECONCILIATION OF SEGMENT GROSS PROFIT
(LOSS) TO SEGMENT ADJUSTED GROSS PROFIT (In
millions, except per barrel data)
|
|
|
|
Three Months Ended
December 31,
|
|
Year Ended
December 31,
|
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
|
(Unaudited)
|
|
Reconciliation of
Segment Gross Profit (Loss) to Segment Adjusted Gross
Profit:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Specialty Products and
Solution segment gross profit
|
|
$
|
62.3
|
|
$
|
88.1
|
|
$
|
189.0
|
|
$
|
402.2
|
|
LCM/LIFO inventory
(gain) loss
|
|
|
(1.1)
|
|
|
(0.4)
|
|
|
0.2
|
|
|
(2.1)
|
|
Other adjustments
(1)
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9.5)
|
|
RINs mark to market
(gain) loss
|
|
|
(28.1)
|
|
|
(40.6)
|
|
|
(45.0)
|
|
|
(176.1)
|
|
Depreciation and
amortization
|
|
|
17.5
|
|
|
22.5
|
|
|
70.3
|
|
|
76.5
|
|
Specialty Products and
Solutions segment Adjusted gross profit
|
|
$
|
50.6
|
|
$
|
69.6
|
|
$
|
214.5
|
|
$
|
291.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance Brands
segment gross profit
|
|
$
|
25.2
|
|
$
|
16.1
|
|
$
|
95.3
|
|
$
|
82.1
|
|
LCM/LIFO inventory
loss
|
|
|
(0.2)
|
|
|
(0.2)
|
|
|
0.6
|
|
|
2.0
|
|
Other adjustments
(2)
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(8.2)
|
|
Depreciation and
amortization
|
|
|
0.7
|
|
|
0.6
|
|
|
2.7
|
|
|
2.6
|
|
Performance Brands
segment Adjusted gross profit
|
|
$
|
25.7
|
|
$
|
16.5
|
|
$
|
98.6
|
|
$
|
78.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Montana/Renewables
segment gross profit (loss)
|
|
$
|
(3.9)
|
|
$
|
(82.1)
|
|
$
|
(53.5)
|
|
$
|
(32.6)
|
|
LCM/LIFO inventory
(gain) loss
|
|
|
4.7
|
|
|
26.8
|
|
|
11.5
|
|
|
35.7
|
|
Loss on firm purchase
commitments
|
|
|
—
|
|
|
22.2
|
|
|
8.5
|
|
|
50.6
|
|
RINs mark to market
(gain) loss
|
|
|
(12.2)
|
|
|
(20.1)
|
|
|
(21.4)
|
|
|
(89.1)
|
|
Depreciation and
amortization
|
|
|
30.5
|
|
|
33.9
|
|
|
106.8
|
|
|
95.2
|
|
Montana/Renewables
segment Adjusted gross profit
|
|
$
|
19.1
|
|
$
|
(19.3)
|
|
$
|
51.9
|
|
$
|
59.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported Specialty
Products and Solutions segment gross profit per barrel
|
|
$
|
11.00
|
|
$
|
16.11
|
|
$
|
8.26
|
|
$
|
18.73
|
|
LCM/LIFO inventory
(gain) loss per barrel
|
|
|
(0.19)
|
|
|
(0.07)
|
|
|
0.01
|
|
|
(0.10)
|
|
Other adjustments per
barrel
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.44)
|
|
RINs mark to market
(gain) loss per barrel
|
|
|
(4.96)
|
|
|
(7.42)
|
|
|
(1.97)
|
|
|
(8.20)
|
|
Depreciation and
amortization per barrel
|
|
|
3.08
|
|
|
4.11
|
|
|
3.08
|
|
|
3.57
|
|
Specialty Products and
Solutions segment Adjusted gross profit per barrel
|
|
$
|
8.93
|
|
$
|
12.73
|
|
$
|
9.38
|
|
$
|
13.56
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported Performance
Brands segment gross profit per barrel
|
|
$
|
170.27
|
|
$
|
135.29
|
|
$
|
152.24
|
|
$
|
160.35
|
|
LCM/LIFO inventory loss
per barrel
|
|
|
(1.35)
|
|
|
(1.68)
|
|
|
0.96
|
|
|
3.91
|
|
Other adjustments per
barrel
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16.02)
|
|
Depreciation and
amortization per barrel
|
|
|
4.73
|
|
|
5.05
|
|
|
4.31
|
|
|
5.08
|
|
Performance Brands
segment Adjusted gross profit per barrel
|
|
$
|
173.65
|
|
$
|
138.66
|
|
$
|
157.51
|
|
$
|
153.32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported
Montana/Renewables segment gross profit (loss) per
barrel
|
|
$
|
(1.87)
|
|
$
|
(45.76)
|
|
$
|
(6.14)
|
|
$
|
(4.56)
|
|
LCM/LIFO inventory
(gain) loss per barrel
|
|
|
2.25
|
|
|
14.94
|
|
|
1.32
|
|
|
4.99
|
|
Loss on firm purchase
commitments per barrel
|
|
|
—
|
|
|
12.37
|
|
|
0.98
|
|
|
7.08
|
|
RINs mark to market
(gain) loss per barrel
|
|
|
(5.85)
|
|
|
(11.20)
|
|
|
(2.45)
|
|
|
(12.46)
|
|
Depreciation and
amortization per barrel
|
|
|
14.62
|
|
|
18.89
|
|
|
12.24
|
|
|
13.31
|
|
Montana/Renewables
segment Adjusted gross profit per barrel
|
|
$
|
9.15
|
|
$
|
(10.76)
|
|
$
|
5.95
|
|
$
|
8.36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Specialty Products and
Solutions Adjusted EBITDA
|
|
$
|
43.4
|
|
$
|
75.6
|
|
$
|
193.6
|
|
$
|
251.2
|
|
Specialty Products and
Solutions sales
|
|
|
647.5
|
|
|
708.4
|
|
|
2,789.3
|
|
|
2,876.9
|
|
Specialty Products and
Solutions Adjusted EBITDA margin
|
|
|
6.7
|
%
|
|
10.7
|
%
|
|
6.9
|
%
|
|
8.7
|
%
|
|
|
|
|
|
|
|
|
|
(1)
|
For the year ended
December 31, 2023, other adjustments for the Specialty Products and
Solutions segment included a $9.5 million gain for proceeds
received under the Company's property damage insurance
policy.
|
(2)
|
For the year ended
December 31, 2023, other adjustments for the Performance Brands
segment included a $8.2 million gain for proceeds received under
the Company's business interruption insurance policy.
|
View original
content:https://www.prnewswire.com/news-releases/calumet-reports-fourth-quarter-and-fiscal-year-2024-results-302388458.html
SOURCE Calumet Specialty Products Partners, L.P.